1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Alonso-Gordoa T, Fernández-Calvo O, García-Carbonero I, Álvarez-Rodríguez S, Sánchez-Escribano R, Anguera G, González-Del-Alba A, Gallardo E, Cacho D, Vidal N, Pinto Á, Perezagua C, Zafra-Poves M, Cassinello J, Rodriguez-Vida A, López-Campos F, Vázquez-Estévez S.

    Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

    Clinical & Translational Oncology . 28(6): 2360-2368.

    [doi:10.1007/s12094-025-04174-8]

  • Longoni M, Scilipoti P, De Angelis M, Zaurito P, Tremolada G, Santangelo A, Simone G, Mastroianni R, Lonati C, Zamboni S, Suardi N, Marcq G, Szostek A, Velasco JC, Lafuente Puentedura A, Subiela JD, Del Olmo Durán P, Slusarczyk A, Karakiewicz PI, Pradere B, Soria F, Gontero P, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes.

    European Urology Oncology . 9(3): 619-627. Nº de citas: 2

    [doi:10.1016/j.euo.2026.02.005]

  • Delgado-Marín M, Sánchez-Esteban S, Cook-Calvete A, Castro-Pinto M, López-Menendez J, Hernandez I, Zamorano JL, Zaragoza C, Saura M.

    ILK-Dependent Modulation of DPP4 Prevents Progression of Calcific Aortic Valve Disease.

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY . 46(6): .

    [doi:10.1161/ATVBAHA.125.323824]

  • Cook-Calvete A, Delgado-Marín M, Jorquera Ortega S, Moreta S, Castro-Pinto M, López-Menendez J, Rodríguez-Fernandez B, García-García J, Zaragoza C, Saura M.

    Endothelial Integrin-Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase-1 (RIPK1) Enriched-Extracellular Vesicle Signalling.

    Journal of Extracellular Vesicles . 15(6): .

    [doi:10.1002/jev2.70335]

  • Slusarczyk A, Scilipoti P, Contieri R, Krajewski W, Claps F, Subiela JD, Mertens LS, Mori K, Grobet-Jeandin E, Velasco JC, Tully K, Soria F, Duran PDO, Puentedura AL, Lijnen RAG, Longoni M, Marcq G, Mari A, Laukhtina E, Afferi L, Albisinni S, Gallioli A, Del Giudice F, Boorjian SA, Briganti A, Shariat SF, Gontero P, Radziszewski P, Moschini M, Pradere B.

    Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

    BJU INTERNATIONAL . 137(6): 1076-1087.

    [doi:10.1111/bju.70231]

  • Contieri R, Martini A, Furrer M, D'Andrea D, Claps F, von Deimling M, Soria F, Mari A, Bianchi L, Tonin E, Flippot R, Teoh JYC, Marcq G, Desprez PE, Pichler R, Slusarczyk A, Subiela JD, Del Giudice F, Santarelli V, Porreca A, Amodeo A, Pavan N, Simonato A, Scilipoti P, Perdonà S, Gontero P, van Rhijn BW, Hurle R, Moschini M, Pradere B, Mertens LS.

    Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

    BJU INTERNATIONAL . 137(6): 1058-1066.

    [doi:10.1111/bju.70232]

  • Zaurito P, Scilipoti P, Longoni M, de Angelis M, Slusarczyk A, Viti A, Santangelo A, Tremolada G, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Marcq G, Gallioli A, Afferi L, Mastroianni R, Simone G, Albisinni S, Mertens LS, Laukhtina E, Oberneder K, Elena JLR, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Mori K, Radziszewski P, Shariat SF, Gontero P, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . 44(6): 61-69.

    [doi:10.1016/j.urolonc.2026.111089]

  • Scilipoti P, Zaurito P, Longoni M, Occhi A, de Angelis M, Disabato N, Tremolada G, Barracco S, Slusarczyk A, Soria F, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Marcq G, Gallioli A, Afferi L, Mastroianni R, Simone G, Albisinni S, Mertens LS, Laukhtina E, Oberneder K, Elena JLR, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Mori K, Radziszewski P, Shariat SF, Gontero P, Rouprêt M, Pradere B, Montorsi F, Briganti A, Moschini M.

    The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . 44(6): 31-40.

    [doi:10.1016/j.urolonc.2026.111085]

  • Sridharan K, Maiorano BA, Rehan F, Maradonna F, Giorgini E, Taha T, Molina-Cerrillo J, Buti S, Piva F, Massari F, Santoni M.

    Microplastics as both a driver of genitourinary cancers and a deliverer of treatments.

    Communications Medicine . 6(1): .

    [doi:10.1038/s43856-026-01675-7]

  • Argente-Pla M, Sampedro-Nuñez MA, Garcia-Carbonero R, Custodio A, Hernando J, Suarez L, Hernandez-Rienda L, Peiró I, Alonso V, Serrano R, Valdés N, Melian M, Febrero B, Biarnes J, Díaz-Pérez JÁ, Molina-Cerrillo J, Lopez C, Martínez Olmos MÁ, Merino-Torres JF, Capdevila J, Del Olmo-García M.

    A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) study.

    Frontiers in Nutrition . 13: 1789458-1789458.

    [doi:10.3389/fnut.2026.1789458]

  • Scilipoti P, Zaurito P, Longoni M, Tremolada G, Occhi A, Dutto D, Katzendorn O, Krajewski W, Laukhtina E, Elena JLR, Aranda J, Contieri R, Hurle R, Subiela JD, Lucena PE, Fernández A, Marcq G, Szostek A, Pichler R, Álvarez-Maestro M, Bazán AA, Klatte T, du Biest AM, Ferrando V, Buisan O, López AV, Soria F, Pradere B, D Andrea D, Shariat SF, Colecchia M, Montorsi F, Briganti A, Gontero P, Xylinas E, Moschini M.

    Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer.

    BJU INTERNATIONAL . 137(5): 821-828.

    [doi:10.1111/bju.70182]

  • Fernández-Mardomingo A, Subiela JD, Artiles Medina A, Krajewski W, Pichler R, van Creij NCH, de la Estella Lucena MP, de la Parra I, Mínguez Ojeda C, Coloma A, Crespo Martínez L, Del Olmo Durán P, González-Padilla DA, Villacampa F, Aumatell J, Scilipoti P, Longoni M, Moschini M, de Angelis M, Caño-Velasco J, Contieri R, Gallioli A, D'Andrea D, Acosta EA, Ajami T, Grobet-Jeandin E, Del Giudice F, Santarelli V, Slusarczyk A, Albisinni S, Soria F, Mertens LS, Tully K, Mari A, Guerrero-Ramos F, Alvarez-Maestro M, Anagua Melendres F, Buisan O, Afferi L, Gajate P, Guerrero P, Saiz A, Pradere B, Burgos Revilla FJ.

    Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

    BJU INTERNATIONAL . 137(5): 866-876.

    [doi:10.1111/bju.70207]

  • Di Bello F, Pradere B, Laukhtina E, D'Andrea D, Giudice FD, Chung BI, Krajewski W, Zattoni F, Soria F, Afferi L, Marcq G, De Lorenzis E, Moschini M, Mari A, Subiela JD, Albisinni S, Izquierdo P, Diéguez L, Avesani G, Territo A, Basile G, Palou J, Breda A, Gallioli A.

    Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancer.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . 44(5): 111064-111064.

    [doi:10.1016/j.urolonc.2026.111064]

  • González-Padilla DA, Subiela JD, Guerrero-Ramos F, Pichler R, Sánchez-Zalabardo D, Villacampa-Auba F.

    Latest developments in urinary tumor DNA and its current clinical role in urothelial bladder cancer and upper tract urothelial carcinoma.

    CURRENT OPINION IN UROLOGY . 36(3): 219-226.

    [doi:10.1097/MOU.0000000000001373]

  • Cella L, Finocchiaro A, Slusarczyk A, Krajewski W, Caño Velasco J, Subiela JD, Claps F, Grobet-Jeandin E, Del Giudice F, Gallioli A, Laukhtina E, Marcq G, Mari A, Afferi L, Albisinni S, Soria F, Hurle R, Paciotti M, Ferro M, Perdonà S, Mertens LS, Moschini M, Pradere B, Contieri R.

    Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

    Future Oncology . 22(11): 1291-1299.

    [doi:10.1080/14796694.2026.2661768]

  • Pischetola A, Socarras MR, de Oliveira TR, Barreras SG, Ortega Polledo LE, Zondervan PJ, Somani BK, Liatsikos E, Veneziano D, Kraft P, Navratil P, Rivas JG, Brinkman WM.

    Consensus-informed Development of Scoring Systems for Intermediate Laparoscopic Simulation Modules: An ESU Laparoscopic Workgroup Initiative.

    European Urology Open Science . 87: 100-106.

    [doi:10.1016/j.euros.2026.03.014]

  • González-Padilla DA, Villacampa-Auba F, Caño-Velasco J, Subiela JD, Rodríguez M, Yánez C, Calva A, Talavera V, Muñoz C, Torres M, Barbas G, Andrés G, Sánchez-Zalabardo D, Guillén-Valderrama EF, Miñana-López B.

    Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma.

    Diagnostics . 16(9): .

    [doi:10.3390/diagnostics16091323]

  • Beas-Lozano EL, Scagliarini S, Valdez-Sandoval PI, Esparza-Orozco MF, Bilen MA, Bamias A, Li H, Juan Fita MJ, Kopecky J, Manneh Kopp R, Ghosn M, Fay AP, Bhuva D, Kucharz J, Büttner T, Molina-Cerrillo J, Fiala O, Rizzo A, Maiorano BA, Soares A, Buti S, Marques Monteiro FS, Massari F, Santoni M, Bourlon MT.

    Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1).

    Frontiers in Immunology . 17: 1805104-1805104.

    [doi:10.3389/fimmu.2026.1805104]